What Analysts Are Saying About BeiGene Stock
Portfolio Pulse from Benzinga Insights
BeiGene (NASDAQ:BGNE) has received mixed analyst ratings over the past three months, with a recent increase in the average 12-month price target to $232.12. Analysts have varied in their outlooks, with some raising their price targets and others lowering them. BeiGene has shown strong revenue growth and net margins, but struggles with ROE and ROA.
September 18, 2024 | 1:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
BeiGene has received a mix of bullish and bearish analyst ratings, with a recent increase in the average price target to $232.12. The company shows strong revenue growth but faces challenges with ROE and ROA.
The increase in the average price target and strong revenue growth are positive indicators for BeiGene's stock. However, challenges with ROE and ROA may temper investor enthusiasm. The mixed analyst ratings reflect this balance of positive and negative factors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100